High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush

被引:79
作者
Brink, Antoinette A. T. P.
Meijer, Chris J. L. M.
Wiegerinck, Maarten A. H. M.
Nieboer, Thedoor E.
Kruitwagen, Roy F. P. M.
van Kemenade, Folkert
Daalmeijer, Nathalie Fransen
Hesselink, Albertus T.
Berkhof, Johannes
Snijders, Peter J. F.
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
[3] Rijnstate Hosp, Arnhem, Netherlands
[4] Maxima Med Ctr, Veldhoven, Netherlands
[5] TweeSteden Hosp, Tilburg, Netherlands
关键词
D O I
10.1128/JCM.02440-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A user-friendly self-sampling method for collecting representative cervical cell material would lower the threshold for women to respond to the invitation for cervical screening. In the present article, we introduce such a device; we have evaluated its sensitivity and specificity to detect high-grade cervical intraepithelial neoplasia (CIN), via high-risk human papillomavirus (hrHPV) detection and liquid-based cytology (LBC), compared to endocervical brush samples obtained by gynecologists. Women who had a cervical smear reading of moderate dyskaryosis or worse or a repeat equivocal Pap smear result in the cervical screening program (n = 64) and healthy volunteers (n = 32) took a self-obtained sample at home prior to their visit to the gynecological outpatient department. At the outpatient department, an endocervical brush smear was taken, followed by colposcopy and biopsy whenever applicable. Both self-obtained samples and endocervical brush samples were immediately collected in Surepath preservation solution and used for LBC and hrHPV testing (by general primer-mediated GP5+/6+ PCR). hrHPV test results showed a good concordance between the two sample types (87%; kappa = 0.71), with sensitivities for prevalent high-grade CIN that did not differ significantly (92% and 95%; P = 1.0). The hrHPV test on self-obtained samples proved to be at least as sensitive for high-grade CIN as cytology on endocervical brush samples (34/37 versus 31/37; P = 0.5). LBC showed a poor concordance between self-obtained and endocervical brush samples (60%; kappa = 0.27). In conclusion, self-obtained samples taken by this novel device are highly representative of the hrHPV status of the cervix. In combination with hrHPV testing, the use of this device may have implications for increasing the attendance rate for cervical screening programs.
引用
收藏
页码:2518 / 2523
页数:6
相关论文
共 38 条
[1]   Low risk of cervical cancer during a long period after negative screening in the Netherlands [J].
Akker-van Marle, MEV ;
van Ballegooijen, M ;
Habbema, JDF .
BRITISH JOURNAL OF CANCER, 2003, 88 (07) :1054-1057
[2]   Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands [J].
Bulk, S ;
Berkhof, J ;
Bulkmans, NWJ ;
Zielinski, GD ;
Rozendaal, L ;
van Kemenade, FJ ;
Snijders, PJF ;
Meijer, CJLM .
BRITISH JOURNAL OF CANCER, 2006, 94 (01) :171-175
[3]   Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women [J].
Bulk, S ;
Visser, O ;
Rozendaal, L ;
Verheijen, RHM ;
Meijer, CJLM .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (06) :1005-1009
[4]   The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996 [J].
Bulk, S ;
van Kemenade, FJ ;
Rozendaal, L ;
Meijer, CJLM .
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (04) :388-393
[5]   Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse [J].
Bulkmans, NWJ ;
Blecker, MCG ;
Berkhof, J ;
Voorhorst, FJ ;
Snijders, PJF ;
Meijer, CJLM .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) :177-181
[6]   Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities [J].
Castle, PE ;
Solomon, D ;
Schiffman, M ;
Wheeler, CM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1066-1071
[7]   A population-based study of vaginal human papillomavirus infection in hysterectomized women [J].
Castle, PE ;
Schiffman, M ;
Bratti, MC ;
Hildesheim, A ;
Herrero, R ;
Hutchinson, ML ;
Rodriguez, AC ;
Wacholder, S ;
Sherman, ME ;
Kendall, H ;
Viscidi, RP ;
Jeronimo, J ;
Schussler, JE ;
Burk, RD .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (03) :458-467
[8]   Human papillomavirus type specific DNA and RNA persistence - Implications for cervical disease progression and monitoring [J].
Cuschieri, KS ;
Whitley, MJ ;
Cubie, HA .
JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (01) :65-70
[9]   HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING [J].
CUZICK, J ;
SZAREWSKI, A ;
TERRY, G ;
HO, L ;
HANBY, A ;
MADDOX, P ;
ANDERSON, M ;
KOCJAN, G ;
STEELE, ST ;
GUILLEBAUD, J .
LANCET, 1995, 345 (8964) :1533-1536
[10]   Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics [J].
Dannecker, C ;
Siebert, U ;
Thaler, CJ ;
Kiermeir, D ;
Hepp, H ;
Hillemanns, P .
ANNALS OF ONCOLOGY, 2004, 15 (06) :863-869